Literature DB >> 18242539

A prospective, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy.

Atul Verma1, Paul Novak, Laurent Macle, Bonnie Whaley, Marianne Beardsall, Zaev Wulffhart, Yaariv Khaykin.   

Abstract

BACKGROUND: Complex fractionated electrograms (CFEs) are continuous electrograms (EGMs) of very short cycle length (CL) representing substrate for atrial fibrillation (AF) perpetuation. Ablation of CFEs may result in AF slowing, termination, and prevention, but identifying them can be subjective.
OBJECTIVE: The purpose of this study was to prospectively assess (1) whether an automated algorithm can identify CFE regions, (2) the acute effects of ablating these regions on AF, and (3) the long-term efficacy as an adjuvant strategy to pulmonary vein antrum isolation (PVAI).
METHODS: Thirty-five patients (three centers, 61 +/- 9 years, left atrium [LA] 43 +/- 9 mm, ejection fraction 53% +/- 7%) with symptomatic paroxysmal (n = 21) or persistent (n = 14) AF were studied. A decapolar lasso (2-mm spacing) was used for mapping. A three-dimensional shell of the LA and pulmonary veins (PVs) was created. If not already in AF, AF was induced by burst pacing (with or without isoproterenol). Atrial EGMs during AF were mapped/analyzed using an automated CFE algorithm. The algorithm measures the time between discrete deflections in a local EGM over 5 seconds (based on selectable width and peak-to-peak [>0.03 mV] criteria). The mean CL of the local EGM is projected onto the LA shell as a color-coded display. Regions of CL <120 ms (published criteria) were targeted for ablation/elimination. Atrial fibrillation cycle length (AFCL) and regularity were measured from the CS. After CFE ablation, further ablation was done to achieve complete PVAI.
RESULTS: AF was spontaneous (n = 20) or induced (n = 15) in all patients. CFEs were most commonly found along the septum (97%), anterior LA (97%), PV antra (83%), base of appendage (83%), and annulus (71%). CFE ablation alone prolonged the AFCL (171 +/- 27 vs. 304 +/- 41 ms; P = .03) and regularized AF to left/right flutter (AFL) in 74% of patients. CFE ablation terminated AF/AFL in 19 patients (54%)-the other 16 were cardioverted-and AF became noninducible in 77%. CFE ablation alone did not cause PV isolation (0.1 +/- 0.3 PV isolated/patient). After combined CFE and PVAI ablation, the single-procedure, off-drug success rate was 83% (follow-up 13 +/- 4 months) versus 71% in matched controls who had PVAI alone (P = .045).
CONCLUSIONS: CFE ablation guided by an automated algorithm resulted in AFCL prolongation, regularization, and noninducibility in most patients. AF terminated in 54% of cases. PVAI with adjuvant CFE ablation has a high efficacy and may be superior to PVAI alone.

Entities:  

Mesh:

Year:  2007        PMID: 18242539     DOI: 10.1016/j.hrthm.2007.09.027

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  37 in total

1.  Pulmonary venous isolation versus additional substrate modification as treatment for paroxysmal atrial fibrillation.

Authors:  Andrew Robertson Gavin; Cameron B Singleton; John Bowyer; Andrew D McGavigan
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials.

Authors:  Melissa H Kong; Jonathan P Piccini; Tristram D Bahnson
Journal:  Europace       Date:  2010-10-30       Impact factor: 5.214

3.  Substrate modification by adding ablation of localized complex fractionated electrograms after stepwise linear ablation in persistent atrial fibrillation.

Authors:  Shiro Nakahara; Tohru Kamijima; Yuichi Hori; Naofumi Tsukada; Akiko Okano; Kan Takayanagi
Journal:  J Interv Card Electrophysiol       Date:  2013-11-30       Impact factor: 1.900

Review 4.  Review on "High-Density Mapping of Atrial Fibrillation in Humans: Relationship Between High-Frequency Activation and Electrogram Fractionation".

Authors:  Yarriv Khaykin
Journal:  J Atr Fibrillation       Date:  2009-02-01

5.  Functional nature of electrogram fractionation demonstrated by left atrial high-density mapping.

Authors:  Amir S Jadidi; Edward Duncan; Shinsuke Miyazaki; Nicolas Lellouche; Ashok J Shah; Andrei Forclaz; Isabelle Nault; Matthew Wright; Lena Rivard; Xingpeng Liu; Daniel Scherr; Stephen B Wilton; Frédéric Sacher; Nicolas Derval; Sebastien Knecht; Steven J Kim; Mélèze Hocini; Sanjiv Narayan; Michel Haïssaguerre; Pierre Jaïs
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-03

6.  Long-term outcomes of adjunctive complex fractionated electrogram ablation to pulmonary vein isolation as treatment for non-paroxysmal atrial fibrillation.

Authors:  Alessandro De Bortoli; Ole-Jørgen Ohm; Per Ivar Hoff; Li-Zhi Sun; Peter Schuster; Eivind Solheim; Jian Chen
Journal:  J Interv Card Electrophysiol       Date:  2013-07-07       Impact factor: 1.900

7.  Automated Detection of Complex Fractionated Atrial Electrograms In Substrate-Based Atrial Fibrillation Ablation: Better Discrimination with a New Setting of CARTO® Algorithm.

Authors:  Julien Seitz; Jérôme Horvilleur; Jérôme Lacotte; Yamina Mouhoub; Fiorella Salerno; Anouska Moynagh; Darach O H-Ici; Mehran Monchi; Laurence Curel; Andre Pisapia
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 8.  Trigger Versus Substrate Ablation for Atrial Fibrillation.

Authors:  Atul Verma
Journal:  J Atr Fibrillation       Date:  2008-07-16

9.  Complex fractionated atrial electrograms: properties of time-domain versus frequency-domain methods.

Authors:  Krzysztof R Grzeda; Sami F Noujaim; Omer Berenfeld; José Jalife
Journal:  Heart Rhythm       Date:  2009-07-16       Impact factor: 6.343

10.  Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial.

Authors:  Atul Verma; Roberto Mantovan; Laurent Macle; Guiseppe De Martino; Jian Chen; Carlos A Morillo; Paul Novak; Vittorio Calzolari; Peter G Guerra; Girish Nair; Esteban G Torrecilla; Yaariv Khaykin
Journal:  Eur Heart J       Date:  2010-03-09       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.